Transcription of 07.315 Rotavirus Vaccine Biological Page
{{id}} {{{paragraph}}}
Alberta Health Services Standard # August 10, 2022 Immunization Program Standards Manual Page 1 of 5 Provincial Population and Public Health Rotavirus Vaccine Biological Page Section 7: Biological Product Information Standard #: Created by: Province-wide Immunization Program, Standards and Quality Approved by: Province-wide Immunization Program, Standards and Quality Approval Date: June 1, 2015 Revised: August 10, 2022 Rotarix RotaTeq Manufacturer GlaxoSmithKline Inc. Merck Canada Inc. Biological Classification Live, attenuated Live, attenuated Indications for Provincially Funded Vaccine Healthy infants starting immunization at 2 months up to and including 19 weeks (19 weeks 6 days) of age. Vaccine will routinely be offered at the 2 and 4 month immunization appointments.
Biological Classification . Live, attenuated . Live, attenuated . Indications for Provincially Funded Vaccine . Healthy infants starting immunization at 2 months up to and including 19 weeks(19 weeks 6 days) of age. • Vaccine will routinely be offered at the 2 …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}